Comparison of efficacy of neoadjuvant endocrine therapy versus neoadjuvant chemotherapy in hormone receptor positive/HER2-negative breast cancer

ZHENG Tao; WANG Geng

doi:10.3969/j.issn.1674-3806.2021.07.14

Home>Articles>Comparison of efficacy of neoadjuvant endocrine therapy versus neoadjuvant chemotherapy in hormone receptor positive/HER2-negative breast cancer

DOI: 10.3969/j.issn.1674-3806.2021.07.14

Comparison of efficacy of neoadjuvant endocrine therapy versus neoadjuvant chemotherapy in hormone receptor positive/HER2-negative breast cancer

ZHENG Tao

WANG Geng

Machine-generated Keywords：

Publication Date：2021-07-28

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：5( 700-704 )

Chinese Journal of New Clinical Medicine

ISSN：1674-3806

Year, Vol.(Issue)：2021,14(7)